Login
$PRZO
$0.50 +$0.02 (3.74%) Close

Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q4 FY2023
As of Dec 31, 2023
CURRENT ASSETS:
Cash and cash equivalents
Short term deposits
Trade receivables
Other current assets
Inventories
TOTAL CURRENT ASSETS
NON-CURRENT ASSETS:
Restricted deposit
Prepaid expenses
Operating lease right-of-use asset
Property and equipment, net
TOTAL NON-CURRENT ASSETS
TOTAL ASSETS
CURRENT LIABILITIES:
Trade payables
Operating lease liabilities
Other current liabilities
TOTAL CURRENT LIABILITIES
NON-CURRENT LIABILITIES:
Derivative warrant liabilities
Operating lease liabilities, net of current portion
TOTAL NON-CURRENT LIABILITIES
SHAREHOLDERS’ EQUITY (DEFICIT):
Ordinary shares, NIS 0.02 par value: Authorized 200,000,000 as of December 31, 2025 and December 31, 2024; Issued and outstanding 19,666,030 and 12,817,092 shares as of December 31, 2025 and as of December 31, 2024, respectively
Additional paid-in capital
Accumulated losses
TOTAL SHAREHOLDERS’ EQUITY (DEFICIT)
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support